Tuesday, September 16, 2014 8:25:28 AM
Better strategies needed to prevent injured workers from abusing opioids
September 16, 2014
A panel of speakers at the 2014 California Workers’ Compensation & Risk Conference called on workers compensation professionals to devise a “comprehensive strategy” to effectively prevent injured workers from abusing opioid drugs, a report on the Business Insurance web site said Thursday.
Roman Kownacki, Occupational Health Services for Kaiser Permanente Northern California’s medical director, noted that the workers compensation sector have to focus on the increasing rate of opioid addiction among its covered workers as regulators reschedule opioids from Schedule III substances to Schedule II.
The U.S. Drug Enforcement Administration announced last month that it would be upscheduling hydrocodone combination drugs, which include opioid analgesics, from Schedule III to Schedule II substances starting October 6.
Schedule II medications cannot be refilled under the same prescription, the report said.
Currently, prescriptions cover refills of up to five months and are valid for six months.
Kownacki also noted that opioid can be a gateway drug to heroin abuse.
“Heroin is a cheaper alternative,” he said. “If you follow the chain of progression, it's possible for somebody to get hooked on opiates from a workers' compensation injury and end up with H.I.V. or hepatitis.”
Patti Williams, Huntington Beach, California risk manager, meanwhile recommended doctors and patients to be “educated” in incorporating a “team-based approach” to prevent patients from getting addicted to their prescriptions.
“A good nurse case manager goes a long way,” Williams told audience at the conference. “You get a lot of bang for your buck.”
Dr. Leonard J. Paulozzi, a medical epidemiologist at CDC’s National Center for Injury Prevention & Control, said in 2013 opioid addiction is a “growing problem” among injured workers.
“The overdose rate is highest among people of working age, that is middle-age people,” he told the Insurance Journal.
Paulozzi added that workers who are more vulnerable to opioid addiction are those suffering from back injuries because their doctors tend to overprescribe the medicine.
“There’s an awful lot of back injuries in the workers’ comp population and subsequent surgery related to back problems, and back pain is one of the most common indications now of use of opioids in the United States,” he said. “And it’s being used frequently for back pain and it’s being used long-term for back pain.”
According to a statement released by the DEA, seven million Americans abuse prescription drugs, including opioid painkillers, which result to “more deaths from prescription drug overdoses than auto accidents.”
“Over prescription continues to be a problem. Part of the problem is that pain is very subjective and doctors may be afraid that they will under prescribe, leaving their patient uncomfortable and unhappy,” said Brady Granier, Chief Operating Officer of BioCorRx, Inc. (OTCQB: BICX), the company that developed the Start Fresh Program.
The Start Fresh Program is a two-tiered program that takes a different approach to addiction rehabilitation. The first phase of the program involves an outpatient medical procedure to embed a specially formulated, biodegradable naltrexone implant under the skin and fatty tissue in the lower abdominal area.
The second tier of the program involves a private, one-on-one coaching program to address the specific needs of the individual and to help him or her plan for a life free from substance abuse.
For more information on BioCorRx, Inc.’s Start Fresh Program, you may reach the company’s headquarters via phone: 714-462-4880, or visit www.startfreshprogram.com
Recent BICX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 12:42:39 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/17/2024 09:15:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 09:30:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 09:59:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:47:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 08:25:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 09:15:15 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 04:37:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/02/2023 07:55:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 11:38:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 09:01:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:56:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:50:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:38:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2023 08:30:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 07:40:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:05:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:04:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:04:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:03:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/05/2023 09:03:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM